OpenVSafe by OpenVAERS
Search V-safe

YC2-28389-95452

1 vaccination 2 coded responses 5 check-ins 2 free-text entries 0 call cases
Sex
Female
Age at first dose
46-50
ZIP prefix
891 / NV
Registered
2021-03-18
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-03-15
    Dose 1 — Pfizer-BioNTech
  2. 2021-03-18
    Registered in v-safe
  3. 2021-03-18
    Health check-in — days 1–6 daily, dose 1
    Feeling: Poor · Site: Pain, Redness, Swelling, Itching · Headache, Joint pains
    Adult check-in
  4. 2021-03-19
    Survey response — days 1–6 daily, dose 1
    MedDRA: Lymphadenopathy — Feeling: Fair · Site: Redness, Itching
    Free text: Swollen lymph nodes
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  5. 2021-03-20
    Survey response — days 1–6 daily, dose 1
    MedDRA: Lymphadenopathy — Feeling: Fair · Site: Itching
    Free text: Swollen lymph nodes
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  6. 2021-03-21
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  7. 2021-03-22
    Health check-in — day 7, dose 1
    Feeling: Good · None
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12021-03-15Pfizer-BioNTech

Free text

Release 5 — days 1–6 daily, dose 1

2021-03-19

Systemic reaction (other): Swollen lymph nodes

Release 6 — days 1–6 daily, dose 1

2021-03-20

Systemic reaction (other): Swollen lymph nodes

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SROLymphadenopathy ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release

Loading…